Literature DB >> 11995816

Proteases and the biology of glioma invasion.

Devin K Binder1, Mitchel S Berger.   

Abstract

Despite optimal clinical treatment, the prognosis for malignant gliomas remains poor. One of the primary reasons for treatment failure is not diffuse dissemination, but local invasion. Recently, there has been an increase in information regarding specific molecules that determine the aggressiveness and invasion potential of high-grade astrocytic tumors. In particular, expression of matrix metalloproteases in high-grade gliomas appears to correlate with tissue invasiveness. It is the purpose of the present review to describe the connection between alterations in growth-related genes, protease activity, and tumor biology, and how these connections may suggest potential novel therapeutic targets.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11995816     DOI： 10.1023/a:1014566604005

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  97 in total

Review 1.  Growth factor control of extracellular proteolysis.

Authors:  D B Rifkin; D Moscatelli; J Bizik; N Quarto; F Blei; P Dennis; R Flaumenhaft; P Mignatti
Journal:  Cell Differ Dev       Date:  1990-12-02

Review 2.  Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth.

Authors:  D Monard
Journal:  Trends Neurosci       Date:  1988-12       Impact factor: 13.837

3.  Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis.

Authors:  J T Rutka; C A Myatt; J R Giblin; R L Davis; M L Rosenblum
Journal:  Can J Neurol Sci       Date:  1987-02       Impact factor: 2.104

4.  Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.

Authors:  M Hermansson; M Nistér; C Betsholtz; C H Heldin; B Westermark; K Funa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.

Authors:  D R Shalinsky; J Brekken; H Zou; C D McDermott; P Forsyth; D Edwards; S Margosiak; S Bender; G Truitt; A Wood; N M Varki; K Appelt
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

6.  Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Authors:  J S Rao; P A Steck; S Mohanam; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

7.  Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy.

Authors:  B C Liang; A F Thornton; H M Sandler; H S Greenberg
Journal:  J Neurosurg       Date:  1991-10       Impact factor: 5.115

8.  Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.

Authors:  W T Couldwell; J P Antel; V W Yong
Journal:  Neurosurgery       Date:  1992-10       Impact factor: 4.654

Review 9.  Protein kinase C and growth regulation of malignant gliomas.

Authors:  G H Baltuch; N P Dooley; J G Villemure; V W Yong
Journal:  Can J Neurol Sci       Date:  1995-11       Impact factor: 2.104

10.  White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues.

Authors:  T Yamada; Y Yoshiyama; H Sato; M Seiki; A Shinagawa; M Takahashi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088
View more
  18 in total

1.  Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.

Authors:  Ryota Tamura; Kentaro Ohara; Hikaru Sasaki; Yukina Morimoto; Kazunari Yoshida; Masahiro Toda
Journal:  J Neurooncol       Date:  2017-11-29       Impact factor: 4.130

2.  Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.

Authors:  Márcia Santos Pereira; Sónia Pires Celeiro; Ângela Margarida Costa; Filipe Pinto; Sergey Popov; Gisele Caravina de Almeida; Júlia Amorim; Manuel Melo Pires; Célia Pinheiro; José Manuel Lopes; Mrinalini Honavar; Paulo Costa; José Pimentel; Chris Jones; Rui Manuel Reis; Marta Viana-Pereira
Journal:  Cell Oncol (Dordr)       Date:  2019-11-07       Impact factor: 6.730

3.  Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population.

Authors:  Nitin Malik; Raj Kumar; Kashi N Prasad; Priyanka Kawal; Arun Srivastava; Ashok K Mahapatra
Journal:  J Neurooncol       Date:  2010-08-14       Impact factor: 4.130

4.  Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.

Authors:  Shilpa Puli; James C K Lai; Alok Bhushan
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

Review 5.  Microsurgery for malignant gliomas.

Authors:  M Gazi Yaşargil; Paulo A S Kadri; Dianne C H Yasargil
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

6.  The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo.

Authors:  Peiyu Pu; Chunsheng Kang; Jie Li; Hao Jiang; Jinquan Cheng
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

7.  The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility.

Authors:  Bin Hu; Leopold L Kong; Russell T Matthews; Mariano S Viapiano
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

8.  Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence.

Authors:  Hyung-Do Kim; Tiffany W Guo; Angela P Wu; Alan Wells; Frank B Gertler; Douglas A Lauffenburger
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

Review 9.  Mechanisms of angiogenesis in gliomas.

Authors:  O Kargiotis; J S Rao; A P Kyritsis
Journal:  J Neurooncol       Date:  2006-03-23       Impact factor: 4.130

10.  Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.

Authors:  Steen J Madsen; Marlon S Mathews; Even Angell-Petersen; Chung-Ho Sun; Van Vo; Rogelio Sanchez; Henry Hirschberg
Journal:  J Neurooncol       Date:  2008-09-06       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.